
Harvard Bioscience HBIO
$ 4.56
5.78%
Annual report 2025
added 03-13-2026
Country |
|
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
44.4 M |
Market Cap[1] |
$ 202 M |
EBITDA (LTM) |
$ -48.4 M |
P/E (LTM) |
-3.24 |
P/S (LTM) |
2.26 |
EPS (LTM) |
-1.33 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
$ 19.92 | 0.91 % | $ 918 M | Nasdaq Global Select Market | ||
|
AtriCure
ATRC
|
$ 27.96 | -0.97 % | $ 1.34 B | Nasdaq Global Market,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 57.54 | 0.38 % | $ 2.9 B | NYSE,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Repro Med Systems
KRMD
|
$ 4.22 | 0.12 % | $ 195 M | Nasdaq Capital Market | ||
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Microbot Medical
MBOT
|
$ 2.37 | -8.49 % | $ 109 M | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Alcon
ALC
|
$ 78.74 | 0.94 % | $ 40.4 B | NYSE | ||
|
Ekso Bionics Holdings
EKSO
|
$ 9.3 | 3.1 % | $ 22.6 M | Nasdaq Capital Market | ||
|
The Cooper Companies
COO
|
$ 71.04 | -0.24 % | $ 14.1 B | NYSE,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.7 | 2.13 % | $ 21 M | NYSE American | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
STERIS plc
STE
|
$ 222.75 | 0.08 % | $ 22 B | NYSE,SPB | ||
|
electroCore
ECOR
|
$ 6.38 | 4.93 % | $ 54.1 K | Nasdaq Global Select Market | ||
|
Masimo Corporation
MASI
|
$ 178.32 | - | $ 9.5 B | Nasdaq Global Select Market,SPB | ||
|
Teleflex Incorporated
TFX
|
$ 120.6 | 1.87 % | $ 5.38 B | NYSE,SPB | ||
|
iRhythm Technologies
IRTC
|
$ 118.78 | 3.07 % | $ 3.8 B | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | 2.33 % | $ 23 M | NYSE American | ||
|
Merit Medical Systems
MMSI
|
$ 69.51 | 1.83 % | $ 4.11 B | Nasdaq Global Select Market,SPB | ||
|
Glaukos Corporation
GKOS
|
$ 117.51 | 0.95 % | $ 5.69 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 125.87 | 0.15 % | $ 3.1 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.62 | 2.56 % | $ 199 M | NYSE American | ||
|
Envista Holdings Corporation
NVST
|
$ 26.52 | 0.49 % | $ 4.46 B | NYSE | ||
|
Utah Medical Products
UTMD
|
$ 66.0 | 0.15 % | $ 214 M | Nasdaq Global Select Market | ||
|
Pro-Dex
PDEX
|
$ 51.26 | -0.43 % | $ 169 M | Nasdaq Global Select Market | ||
|
Intuitive Surgical
ISRG
|
$ 452.01 | 0.31 % | $ 161 B | Nasdaq Global Select Market,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
LeMaitre Vascular
LMAT
|
$ 113.79 | -0.72 % | $ 2.58 B | Nasdaq Global Market,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 11.8 | 0.73 % | $ 2.35 B | Nasdaq Global Select Market,SPB | ||
|
Baxter International
BAX
|
$ 17.35 | 1.17 % | $ 8.9 B | NYSE,SPB | ||
|
ResMed
RMD
|
$ 228.86 | -0.01 % | $ 33.4 B | NYSE,SPB | ||
|
Pulse Biosciences
PLSE
|
$ 18.77 | 0.56 % | $ 1.27 B | Nasdaq Global Select Market | ||
|
Stereotaxis
STXS
|
$ 1.92 | 2.67 % | $ 175 M | NYSE American | ||
|
STAAR Surgical Company
STAA
|
$ 26.51 | 0.27 % | $ 1.31 B | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 257.59 | 0.41 % | $ 18.6 B | NYSE,SPB | ||
|
AngioDynamics
ANGO
|
$ 9.93 | 1.33 % | $ 406 M | Nasdaq Global Select Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 153.62 | -0.39 % | $ 44.2 B | NYSE,SPB | ||
|
Nephros
NEPH
|
$ 2.87 | -3.21 % | $ 29.8 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.07 | 3.55 % | $ 226 M | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 120.28 | 0.15 % | $ 6.7 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.